Argos Therapeutics (FRA:77AA) Change In Inventory : €0.00 Mil (TTM As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Change In Inventory?

Argos Therapeutics's change in inventory for the quarter that ended in Sep. 2018 was €0.00 Mil. It means Argos Therapeutics's inventory stayed the same from Jun. 2018 to Sep. 2018 .

Argos Therapeutics's change in inventory for the fiscal year that ended in Dec. 2017 was €0.00 Mil. It means Argos Therapeutics's inventory stayed the same from Dec. 2016 to Dec. 2017 .

Argos Therapeutics's Total Inventories for the quarter that ended in Sep. 2018 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Argos Therapeutics's Inventory-to-Revenue for the quarter that ended in Sep. 2018 was 0.00.

Argos Therapeutics Change In Inventory Historical Data

The historical data trend for Argos Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Change In Inventory Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Change In Inventory

Get a 7-Day Free Trial

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Argos Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Argos Therapeutics (FRA:77AA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Argos Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Argos Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Argos Therapeutics's Inventory to Revenue for the quarter that ended in Sep. 2018 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	1.069
	=	0.00

Argos Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines